Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-06-001935
Filing Date
2006-03-30
Accepted
2006-03-30 14:43:12
Documents
5
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ALTUS PHARMACEUTICALS, INC. b60010ape10vk.htm 10-K 1148478
2 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b60010apexv21w1.htm EX-21.1 1508
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b60010apexv31w1.htm EX-31.1 8723
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b60010apexv31w2.htm EX-31.2 8752
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO AND CFO b60010apexv32w1.htm EX-32.1 6192
  Complete submission text file 0000950135-06-001935.txt   1175057
Mailing Address 125 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 125 SIDNEY STREET CAMBRIDGE MA 02139 617-299-2900
Altus Pharmaceuticals Inc. (Filer) CIK: 0001340744 (see all company filings)

EIN.: 043573277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51711 | Film No.: 06722588
SIC: 2836 Biological Products, (No Diagnostic Substances)